• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

2
2
2

COUNTRY

2

CATEGORIES

  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

1
1
5
8

PUBLISHED

0
1
3
8

PRODUCT TYPE

7
1

Search "NexMed Inc.-Therapeutic Competitors" returned 8 results.

PRODUCT TITLE

Apricus Biosciences, Inc. (APRI) - Financial and Strategic SWOT Analysis Review

Apricus Biosciences, Inc. (APRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2014
FROM

Ovarian Cancer - Pipeline Review, H2 2014

Ovarian Cancer - Pipeline Review, H2 2014 Summary This, ‘Ovarian Cancer - Pipeline Review, H2 2014’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM
Asia-Pacific Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015 Asia-Pacific Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015 - Product Thumbnail Image

Asia-Pacific Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Asia-Pacific Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015 Summary This report is an essential source for in-depth information and data relating to Asia Pacific drug...

September 2009
FROM
Republic of Korea Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015 Republic of Korea Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015 - Product Thumbnail Image

Republic of Korea Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Republic of Korea Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015 Summary This report is an essential source for in-depth information and data relating to Republic of...

September 2009
FROM

Trends in the Early Diagnosis of Cardiovascular Disease: Worldwide Market Opportunities

Despite dramatic improvements in both diagnosis and therapy, cardiovascular disease remains the leading cause of mortality in the developed world. Worldwide more than $54 billion was spent on cardiac...

October 2001
North America In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 North America In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 - Product Thumbnail Image

North America In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

This report is an essential source for in-depth information and data relating to North America In vitro diagnostic dvices market It also offers detailed and comprehensive coverage of market revenue,...

December 2009
FROM

Drug Delivery Series I-IV (Oral, Implantable/Injectable, Pulmonary and Transdermal/Transmucosal Systems)

Novel pharmacological and biological approaches to disease are calling for novel systems of delivering therapies. This has focused attention on the market for drug delivery systems and the pharmaceuticals...

April 2007
FROM

Pet Medications in the U.S.: Over-the-Counter and Prescription Remedies as Consumer Products, 3rd Edition

The market for pet medications in the U S is experiencing considerable activity Longtime flea and tick leader Frontline (from Merial) is finally feeling the effects of the patent expiration of its active...

January 2014
FROM
Loading Indicator

Our Clients

Hexcel Corporation Harrods Ltd. Bayer AG Google, Inc. Boeing Company Harley Davidson Motor Company SwissCom AG